CF
HLVX

Corebridge Financial’s HilleVax HLVX Stock Holding History

Corebridge Financial’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,441
Closed -$22.4K – 1221
2025
Q1 		$22.4K Sell
15,441
-229
-1% -$423 ﹤0.01% 2891
2024
Q4 		$32.4K Sell
15,670
-1,183
-7% -$2.22K ﹤0.01% 2912
2024
Q3 		$29.7K Sell
16,853
-103
-0.6% -$264 ﹤0.01% 2952
2024
Q2 		$245K Buy
+16,956
New +$233K ﹤0.01% 2071

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
LMC
Lightspeed Management Company Menlo Park, California $988M AUM 7.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Corebridge Financial's HLVX Position: Q2 2025 in Review

Corebridge Financial sold out of HilleVax (HLVX) in Q2 2025, closing a stake of 15,441 shares — an estimated $22.4K sold.

Corebridge Financial first reported a position in HLVX in Q2 2024 and held it in 4 quarters. The position peaked at $245K in Q2 2024. 74 funds tracked by Wall St. Rank hold HLVX as of Q2 2025.

  • Corebridge Financial reported no remaining HilleVax position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 15,441 HilleVax shares in Q2 2025, an estimated $22.4K.
  • Corebridge Financial first reported a position in HilleVax in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's HilleVax position peaked at $245K in Q2 2024.
  • 74 funds tracked by Wall St. Rank held HilleVax as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.